MGTX
NASDAQMeiraGTx Holdings plc
Price$12.42+0.34 (+2.81%)
01:30 PM07:45 PM
News · 26 weeks63-20%
2026-01-182026-07-12
Mix3590d
- Insider21(60%)
- SEC Filings9(26%)
- Other5(14%)
Latest news
25 items- INSIDERCHIEF SCI OFCR, OPHTHALMOLOGY Naylor Stuart sold $409,470 worth of Ordinary Shares (27,659 units at $14.80) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 640,846 units (SEC Form 4)4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- SECMeiraGTx Holdings plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MeiraGTx Holdings plc (0001735438) (Filer)
- PRMeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland Capital to receive low single-digit capped royalties on the net sales of each of AAV2-hAQP1 for the treatment of grade 2/3 late radiation-induced xerostomia (RIX), botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP), and AAV-AIPL1 for the treatment of LCA4 LONDON and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage genetic medicines company, today announced that it has entered into an agreement with Oberland Capital Management LLC (Obe
- INSIDERSEC Form 4 filed by CHIEF MEDICAL OFFICER Zeldin Robert K4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by GENERAL COUNSEL AND SECRETARY Wollin Robert J4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by CHIEF SCI OFCR, OPHTHALMOLOGY Naylor Stuart4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by CFO & COO Giroux Richard4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT & CEO Forbes Alexandria4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Yu Debra4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Shenk Thomas E4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Seligman Nicole4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Mendoza Neil4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Hukkelhoven Ellen4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 4 filed by Director Harris Keith R.4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- SECMeiraGTx Holdings plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - MeiraGTx Holdings plc (0001735438) (Filer)
- INSIDERSEC Form 4 filed by Director Perceptive Advisors Llc4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERDirector Harris Keith R. converted options into 75,000 units of Ordinary Shares, increasing direct ownership by 60% to 200,000 units (SEC Form 4)4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERCFO & COO Giroux Richard gifted 7,000 units of Ordinary Shares, decreasing direct ownership by 0.72% to 964,530 units (SEC Form 4)4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERPRESIDENT & CEO Forbes Alexandria sold $568,540 worth of Ordinary Shares (62,000 units at $9.17) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 1,387,695 units (SEC Form 4)4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- SECSEC Form 144 filed by MeiraGTx Holdings plc144 - MeiraGTx Holdings plc (0001735438) (Subject)
- INSIDERSEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Fleck Penny Renee4 - MeiraGTx Holdings plc (0001735438) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fleck Penny Renee3 - MeiraGTx Holdings plc (0001735438) (Issuer)
- PRMeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)LONDON and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that the Compensation Committee of the Company's Board of Directors approved equity awards to Penny Fleck in connection with her employment with the Company as Chief Development Officer. The equity awards were granted as an inducement material to the new employee entering employment with MeiraGTx in accordance with Nasdaq Listing Rule 5635(c)(4). Ms. Fleck received equity awards comprised of (i) non-qualified stock options to purchase 100,000 shares of the Company's ordinary shares with an exercise price equal to $9.9
- SECSEC Form 10-Q filed by MeiraGTx Holdings plc10-Q - MeiraGTx Holdings plc (0001735438) (Filer)
- SECMeiraGTx Holdings plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MeiraGTx Holdings plc (0001735438) (Filer)
MGTX FAQ
7 questionsWhat does MeiraGTx Holdings plc do?
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced...Where does MGTX stock trade?
MeiraGTx Holdings plc (MGTX) is listed on NASDAQ.What sector and industry is MGTX in?
MeiraGTx Holdings plc operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did MeiraGTx Holdings plc go public?
MeiraGTx Holdings plc (MGTX) completed its IPO in 2018.What are analysts saying about MGTX?
MeiraGTx Holdings plc has had 3 recent analyst actions on file. The most recent action was from H.C. Wainwright: Buy with a $2000.00 price target on 2025-11-24. Recent price targets range from $2000.00 to $3600.00.What companies are similar to MGTX?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare MGTX side-by-side with any of them on Quantisnow.How can I track MGTX on Quantisnow?
Quantisnow aggregates MeiraGTx Holdings plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MGTX to receive live email and push alerts on every new disclosure.